Literature DB >> 22977259

Delayed cutaneous wound healing in Fam129b/Minerva-deficient mice.

Hisashi Oishi1, Susumu Itoh, Ken Matsumoto, Hiroyuki Ishitobi, Rumiko Suzuki, Masatsugu Ema, Takahiro Kojima, Kazuhiko Uchida, Mitsuyasu Kato, Toshio Miyata, Satoru Takahashi.   

Abstract

A recent integrative analysis using a phosphoproteomic approach identified FAM129B, also known as MINERVA, as a downstream effector of the MAP kinase pathway in human melanoma cells. FAM129B protein, which is a member of a small family of proteins, was also found to suppress TNFα/cycloheximide-induced apoptosis in HeLa cells. To investigate the physiological functions of Fam129b in vivo, we generated gene-targeted Fam129b-mutant mice in which, the amino terminal coding exon was replaced by lacZ. We found that homozygous mutant mice are viable and fertile and that Fam129b is considerably expressed in most of the epidermal keratinocytes of both embryonic and adult mice. Although no gross defect was observed in the skin of the Fam129b-deficient mice, wound healing subsequent to skin puncturing was significantly delayed. Furthermore, overexpression of Fam129b promoted HaCaT cell motility in an N-terminal pleckstrin homology domain-dependent manner, but not proliferation. Microarray analysis of the Fam129b transfectant exhibited substantial upregulation of several genes related to wound repair and cell motility. These results suggest that expression of Fam129b in epidermal keratinocytes accompanied by alteration of wound healing-related gene expression is necessary for regulation of cell motility and thereby, contributes to the appropriate wound healing process.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22977259     DOI: 10.1093/jb/mvs100

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  5 in total

1.  A2ML1 and otitis media: novel variants, differential expression, and relevant pathways.

Authors:  Eric D Larson; Jose Pedrito M Magno; Matthew J Steritz; Erasmo Gonzalo D V Llanes; Jonathan Cardwell; Melquiadesa Pedro; Tori Bootpetch Roberts; Elisabet Einarsdottir; Rose Anne Q Rosanes; Christopher Greenlee; Rachel Ann P Santos; Ayesha Yousaf; Sven-Olrik Streubel; Aileen Trinidad R Santos; Amanda G Ruiz; Sheryl Mae Lagrana-Villagracia; Dylan Ray; Talitha Karisse L Yarza; Melissa A Scholes; Catherine B Anderson; Anushree Acharya; Samuel P Gubbels; Michael J Bamshad; Stephen P Cass; Nanette R Lee; Rehan S Shaikh; Deborah A Nickerson; Karen L Mohlke; Jeremy D Prager; Teresa Luisa G Cruz; Patricia J Yoon; Generoso T Abes; David A Schwartz; Abner L Chan; Todd M Wine; Eva Maria Cutiongco-de la Paz; Norman Friedman; Katerina Kechris; Juha Kere; Suzanne M Leal; Ivana V Yang; Janak A Patel; Ma Leah C Tantoco; Saima Riazuddin; Kenny H Chan; Petri S Mattila; Maria Rina T Reyes-Quintos; Zubair M Ahmed; Herman A Jenkins; Tasnee Chonmaitree; Lena Hafrén; Charlotte M Chiong; Regie Lyn P Santos-Cortez
Journal:  Hum Mutat       Date:  2019-05-21       Impact factor: 4.878

2.  FAM129B-dependent activation of NRF2 promotes an invasive phenotype in BRAF mutant melanoma cells.

Authors:  Cody J Schmidlin; Wang Tian; Matthew Dodson; Eli Chapman; Donna D Zhang
Journal:  Mol Carcinog       Date:  2021-03-08       Impact factor: 4.784

3.  FAM129B promoted tumor invasion and proliferation via facilitating the phosphorylation of FAK signaling and associated with adverse clinical outcome of non-small cell lung cancer patients.

Authors:  Xiaoming Zhou; Fangfei Yang; Qin Zhang; Yuan Miao; Xuejun Hu; Ailin Li; Gang Hou; Qiuyue Wang; Jian Kang
Journal:  Onco Targets Ther       Date:  2018-10-25       Impact factor: 4.147

4.  The possible roles of B-cell novel protein-1 (BCNP1) in cellular signalling pathways and in cancer.

Authors:  Sapan J Patel; Gaurang L Trivedi; Costel C Darie; Bayard D Clarkson
Journal:  J Cell Mol Med       Date:  2016-09-29       Impact factor: 5.310

5.  Structural Insight on Functional Regulation of Human MINERVA Protein.

Authors:  Hyunggu Hahn; Dong-Eun Lee; Dong Man Jang; Jiyoun Kim; Yeon Lee; Heesun Cheong; Byung Woo Han; Hyoun Sook Kim
Journal:  Int J Mol Sci       Date:  2020-10-31       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.